St Erik Eye Hospital — Sponsor Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

1 Recruiting

0 Completed trials

1 Countries active

1 Unique IMPs

N/A Results reported

Phase III

Phase I

Top indications

2 total

CellThRPE1 Pending

2024-517546-33-00 Phase I 1 country
AMUM trial -Adjuvant Melatonin for Uveal Melanoma: A randomized open Phase III Study Recruiting

2022-500307-49-00 Phase III 1 country MELATONIN

Showing 1–2 of 2 trials